Your session is about to expire
← Back to Search
Behavioral Intervention
Augmented Reality Training for Learning Difficulties (AR Brazil Trial)
N/A
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Current nausea
History of seizures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after simulation
Awards & highlights
No Placebo-Only Group
Summary
This trial compares the performance of doctors and residents in a simulated Advanced Cardiac Life Support scenario. It will compare two groups: one using traditional in-person simulation and the other using Augmented Reality simulation.
Who is the study for?
This trial is for Brazilian residents who are physicians or medical residents. It's not suitable for individuals with severe motion sickness, current nausea, a history of seizures, or those who wear corrective glasses.
What is being tested?
The study compares traditional in-person clinical simulation training to an Augmented Reality (AR) headset experience for learning Advanced Cardiac Life Support (ACLS). The goal is to see if AR can match the effectiveness of in-person training.
What are the potential side effects?
While using the AR headset might not cause typical medication side effects, participants could potentially experience discomfort like dizziness or headaches due to motion sickness.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently experiencing nausea.
Select...
I have a history of seizures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after simulation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after simulation
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Progression through the ACLS clinical simulation demonstrated by NTS and TS
Secondary study objectives
Demonstration of NTS during ACLS scenario
Evaluation of the AR system's usability
Exploration of perceptions, attitudes, and opinions of the AR simulation participants
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Augmented Reality Enhanced Simulation (Treatment group)Experimental Treatment1 Intervention
Participants will experience augmented simulations with a holographic mixed-reality setting based on different workplace scenarios such as medical crisis via Augmented Reality (AR) headset.
Group II: Traditional In Situ Simulation (Control group)Active Control1 Intervention
Participants will experience in-person simulations of different workplace scenarios such as medical error and workplace harassment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Augmented Reality Headset
2022
N/A
~170
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,491 Previous Clinical Trials
17,518,144 Total Patients Enrolled